This webinar offers a comprehensive look at HER2-positive breast cancer, exploring both pathological and molecular aspects of the disease. Participants will gain expert insights into the latest advances in tumour biology, molecular profiling, and diagnostic approaches, as well as their impact on clinical decision-making and patient management. The session is designed to provide a clear and up-to-date understanding of HER2-positive breast cancer, highlighting how cutting-edge research and pathology inform personalised treatment strategies.